Baillie Gifford - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$495,068,448
-12.9%
18,241,284
-1.4%
0.45%
-6.4%
Q2 2023$568,708,076
-16.6%
18,500,588
-2.2%
0.48%
-21.5%
Q1 2023$681,642,562
+0.8%
18,918,750
+10.5%
0.62%
-12.8%
Q4 2022$676,554,025
-5.8%
17,119,282
-4.2%
0.70%
-4.7%
Q3 2022$717,943,000
-5.1%
17,868,175
-0.7%
0.74%
-4.6%
Q2 2022$756,506,000
+1622.9%
17,994,918
+1496.7%
0.78%
+2403.2%
Q1 2022$43,909,0001,127,0310.03%
Other shareholders
ROYALTY PHARMA PLC shareholders Q1 2023
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 3,391,754$134,04264.43%
Vantage Consulting Group Inc 1,022,194$35,462,04720.94%
Indie Asset Partners, LLC 462,000$18,258,24020.01%
Silicon Valley Community Foundation 1,032,320$40,797,2867.84%
Overbrook Management Corp 609,352$24,081,5917.00%
Renaissance Capital LLC 137,462$5,432,4984.24%
Geo Capital Gestora de Recursos Ltd 124,090$4,9043.92%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,974,625$78,037,1803.28%
Lagoda Investment Management, L.P. 119,080$4,706,0423.18%
VIKING GLOBAL INVESTORS LP 10,008,511$395,536,3551.98%
View complete list of ROYALTY PHARMA PLC shareholders